Efficacy of a Single Dose and an Additional Dose of Tranexamic Acid in Reduction of Blood Loss in Total Knee Arthroplasty

Journal of Arthroplasty

Volumn 32, Issue 7, 2017, Pages 2108-2112

  Sun, Qi ^a   Yu, Xiao ^a   Wu, JieZhou ^a   Ge, Wei ^a   Cai, Ming ^a   Li, Shaohua ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

additional administration; blood loss; intravenous administration; total knee arthroplasty; tranexamic acid

Indexed keywords

HEMOGLOBIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAOPERATIVE BLOOD LOSS; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TOTAL KNEE ARTHROPLASTY; TREATMENT DURATION; CHEMICALLY INDUCED; INTRAVENOUS DRUG ADMINISTRATION; KNEE REPLACEMENT; MIDDLE AGED; POSTOPERATIVE PERIOD; STATISTICS AND NUMERICAL DATA; VEIN THROMBOSIS;

ADMINISTRATION, INTRAVENOUS; AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TRANEXAMIC ACID; VENOUS THROMBOSIS;

EID: 85007258175     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.10.003     Document Type: Article

References (25)

1. Maniar, R.N., Kumar, G., Singhi, T., et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res, 470(9), 2012, 2605.
2. Carvalho, L.H. Jr., Frois Temponi, E., Machado Soares, L.F., et al. Bleeding reduction after topical application of tranexamic acid together with Betadine solution in total knee arthroplasty. A randomised controlled study. Orthop Traumatol Surg Res, 101(1), 2015, 83.
3. Huang, Z., Ma, J., Shen, B., et al. Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: a prospective randomized controlled trial. J Arthroplasty, 29(12), 2014, 2342.
4. Reikeras, O., Clementsen, T., Time course of thrombosis and fibrinolysis in total knee arthroplasty with tourniquet application. Local versus systemic activations. J Thromb Thrombolysis, 28(4), 2009, 425.
5. Vamvakas, E.C., Blajchman, M.A., Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood, 113(15), 2009, 3406.
6. Sa-Ngasoongsong, P., Wongsak, S., Chanplakorn, P., et al. Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. BMC Musculoskelet Disord, 14, 2013, 340.
7. Longstaff, C., Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis, 5(4), 1994, 537.
8. Yang, Z.G., Chen, W.P., Wu, L.D., Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am, 94(13), 2012, 1153.
9. Sarzaeem, M.M., Razi, M., Kazemian, G., et al. Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J Arthroplasty, 29(8), 2014, 1521.
10. Gomez-Barrena, E., Ortega-Andreu, M., Padilla-Eguiluz, N.G., et al. Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am, 96(23), 2014, 1937.
11. Gillette, B.P., DeSimone, L.J., Trousdale, R.T., et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res, 471(1), 2013, 150.
12. Alshryda, S., Sarda, P., Sukeik, M., et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br, 93(12), 2011, 1577.
13. Gandhi, R., Evans, H.M., Mahomed, S.R., et al. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes, 6, 2013, 184.
14. Charoencholvanich, K., Siriwattanasakul, P., Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res, 469(10), 2011, 2874.
15. Schreiber, G.B., Busch, M.P., Kleinman, S.H., et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med, 334(26), 1996, 1685.
16. Sinclair, K.C., Clarke, H.D., Noble, B.N., Blood management in total knee arthroplasty: a comparison of techniques. Orthopedics, 32(1), 2009, 19.
17. Tanaka, N., Sakahashi, H., Sato, E., et al. Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br, 83(5), 2001, 702.
18. Pilbrant, A., Schannong, M., Vessman, J., Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol, 20(1), 1981, 65.
19. Barbour, A.M., Schmidt, S., Zhuang, L., et al. Application of pharmacokinetic/pharmacodynamic modelling and simulation for the prediction of target attainment of ceftobiprole against methicillin-resistant Staphylococcus aureus using minimum inhibitory concentration and time-kill curve based approaches. Int J Antimicrob Agents, 43(1), 2014, 60.
20. Fukuda, A., Hasegawa, M., Kato, K., et al. Effect of tourniquet application on deep vein thrombosis after total knee arthroplasty. Arch Orthop Trauma Surg, 127(8), 2007, 671.
21. Lin, P.C., Hsu, C.H., Chen, W.S., et al. Does tranexamic acid save blood in minimally invasive total knee arthroplasty?. Clin Orthop Relat Res, 469(7), 2011, 1995.
22. Dahuja, A., Dahuja, G., Jaswal, V., et al. A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty, 29(4), 2014, 733.
23. Hourlier, H., Reina, N., Fennema, P., Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trial. Arch Orthop Trauma Surg, 135(4), 2015, 465.
24. Nilsson, I.M., Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol), 14, 1980, 41.
25. Iwai, T., Tsuji, S., Tomita, T., et al. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop, 37(3), 2013, 441.